Tag: biologic patent protection
Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Medications
Archives
Recent-posts
Top Motilium Alternatives in 2024 for Effective Nausea Relief
Oct, 28 2024
Nitroglycerin vs Alternatives: Which Angina Treatment Works Best?
Oct, 11 2025
Thalidomide and Teratogenic Medications: History and Lessons
Mar, 30 2026
Debate on Banning Weight-Loss Drugs Alli and Xenical Intensifies Amid Health Concerns
Mar, 22 2024
Batch Release Testing: Final Checks Before Pharmaceutical Distribution
Jan, 29 2026